Acadia Pharmaceuticals Inc. (NASDAQ: ACAD) announced that the U.S. Food and Drug Administration has granted Fast Track designation to remlifanserin ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

FDA